Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Retained Earnings: 2015-2025

Historic Retained Earnings for AC Immune (ACIU) over the last 11 years, with Sep 2025 value amounting to -$524.7 million.

  • AC Immune's Retained Earnings fell 30.29% to -$524.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$524.7 million, marking a year-over-year decrease of 30.29%. This contributed to the annual value of -$524.7 million for FY2025, which is N/A change from last year.
  • AC Immune's Retained Earnings amounted to -$524.7 million in FY2025, which was down 124,728.45% from -$420,353 recorded in FY2024.
  • In the past 5 years, AC Immune's Retained Earnings registered a high of -$356,466 during FY2023, and its lowest value of -$524.7 million during FY2025.
  • In the last 3 years, AC Immune's Retained Earnings had a median value of -$420,353 in 2024 and averaged -$175.2 million.
  • As far as peak fluctuations go, AC Immune's Retained Earnings crashed by 49.64% in 2021, and later spiked by 99.87% in 2023.
  • Yearly analysis of 5 years shows AC Immune's Retained Earnings stood at -$219.9 million in 2021, then fell by 24.63% to -$274.1 million in 2022, then soared by 99.87% to -$356,466 in 2023, then dropped by 17.92% to -$420,353 in 2024, then reached -$524.7 million in 2025.